Mechanism of induction of cell differentiation and cell death by inhibitors against V-ATPase

V-ATP酶抑制剂诱导细胞分化和细胞死亡的机制

基本信息

  • 批准号:
    09672220
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

In this research project, we have studied the machanism of (1) inhibition of cell growth, (2) induction of cell differentiation, and (3) induction of apoptosis, by V-ATPase inhibitors like bafilomycins, prodigiosins and destruxins, as well as the mechanims of inhibition of proton translocation by these inhibitors.We found (1) that both destrauxin-B and -E inhibited lysosomal proton pump, but only destruxin-E induced induced neurite out growth (NOG) of PC12 cells., (2) that prodigisins uncoupled various proton pump activities due to their H ^+ /Cl symport activity, (3) that prodigiosins, like bafilomycin A ^<1'> induced neurite out growth (NOG), and (4) that the prodigiosin-induced NOG, like bafolomycin-induced one, required de novo synthesis of new messenger RNA as well as protein synthesis, was sensitive to the inhibitors of MAP kinases, serine/threonine phosphatases, tyr-kinases, tyr-phosphatases, calmidulin and phospholipase A ^<2' > but resistant to inhibitors of trk tyrosine kinase and protein kinase A.BE-18591, a tambjamine group antibiotics, also behaved as H ^+ /CU symporters and inhibited hog gastric proton pump, inhibit *cid secretion by gastric parietal cells, inhibited osteoclast differentiation, suppressed proliferation of immune lymphocytes, and induced both NOG and apoptosis, suggesting that the variety of biological activities displayed by these H ^+ /C1 symporters may be due to their H ^+ /C1 symport activity. However, tetrapyrrole, another H ^+ /CV symporter, did not induced NOG.From these results, we conclud that the effect of V-ATPase inhibitors on the intracellular pH does not participate in the variety of biological activities (including induction of NOG) displayed by these compounds.
在本课题中,我们研究了V-ATPase抑制剂如巴菲霉素、prodigiosins和destruxins对细胞生长的抑制、对细胞分化的诱导、对细胞凋亡的诱导机制,以及这些抑制剂对质子易位的抑制机制。我们发现(1)消曲素- b和-E均能抑制溶酶体质子泵,但只有消曲素-E能诱导PC12细胞的诱导神经突外生长(NOG)。(2)由于其H ^+ /Cl同调活性,prodigisins使各种质子泵活性解耦;(3)prodigisins与巴霉素A ^<1'>一样诱导神经突起生长(neurite out growth, NOG); (4) prodigisins诱导的NOG与巴霉素诱导的NOG一样,需要重新合成新的信使RNA和蛋白质合成,对MAP激酶、丝氨酸/苏氨酸磷酸酶、酪氨酸激酶、酪氨酸磷酸酶、酪氨酸磷酸酶的抑制剂敏感。但对trk酪氨酸激酶和蛋白激酶A. be -18591抑制剂有耐药性的calmidulin和磷脂酶A ^<2' >也作为H ^+ /CU同调体,抑制猪胃质子泵,抑制胃壁细胞分泌*酸,抑制破骨细胞分化,抑制免疫淋巴细胞增殖,诱导NOG和凋亡。提示这些H ^+ /C1同调体表现出的生物活性的多样性可能是由于它们的H ^+ /C1同调活性。然而,另一种H ^+ /CV同调体四吡咯没有引起NOG。从这些结果,我们得出结论,v - atp酶抑制剂对细胞内pH的影响并不参与这些化合物所显示的各种生物活性(包括诱导NOG)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shoji Ohkuma: "Prodigiosins uncouple lysosomal vacuolar-type ATPase through promotion of H^+/Cl^- symport" Biochem.J.334. 731-741 (1998)
Shoji Ohkuma:“灵菌红素通过促进 H^ /Cl^- symport 解偶联溶酶体液泡型 ATP 酶”Biochem.J.334。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ohkuma, S., Sato, T., Okamoto, M., Matsuya, H., Arai, K., Kataoka, T., Nagai, K., and Wasserman, H.H.: "Prodigiosins uncouple lysosomal vacuolar-type ATPase through promotion of H^+/Cl^- symport." Biochem.J.334. 731-741 (1998)
Ohkuma, S.、Sato, T.、Okamoto, M.、Matsuya, H.、Arai, K.、Kataoka, T.、Nagai, K. 和 Wasserman, H.H.:“灵菌红素通过促进作用解偶联溶酶体液泡型 ATP 酶
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tetsuo Ohta: "Bafilomycin A_1 induces apoptosis in human pancreatic cancer cell line capan-1." J.Pathol.185. 324-330 (1998)
Tetsuo Ohta:“Bafilomycin A_1 诱导人胰腺癌细胞系 capan-1 凋亡。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kunizo Arai: "ARF-induced lysosomal lysis in vitro." J.Biochem.(Tokyo). 123. 637-643 (1998)
Kunizo Arai:“ARF 诱导的体外溶酶体裂解。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OHKUMA Shoji其他文献

OHKUMA Shoji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OHKUMA Shoji', 18)}}的其他基金

V-ATPase Inhibitor, pH and Cell Growth Inhibition
V-ATP 酶抑制剂、pH 值和细胞生长抑制
  • 批准号:
    14370741
  • 财政年份:
    2002
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Control mechanisms of autophagy and apoptosis by a new group H^+/Cl^- symporting antibiotics
新型H^/Cl^-同向抗生素控制自噬和凋亡的机制
  • 批准号:
    11470483
  • 财政年份:
    1999
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Search for cell-death inducing antitumor agents based on the anti-tumor activity of V-ATPase inhibitors
基于V-ATP酶抑制剂的抗肿瘤活性寻找细胞死亡诱导抗肿瘤药物
  • 批准号:
    10557221
  • 财政年份:
    1998
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).

相似海外基金

Proton pump-initiated synthesis of a conductive polypyrrole for genetically targeted chemical assembly on living neurons
质子泵引发的导电聚吡咯合成,用于活体神经元上的基因靶向化学组装
  • 批准号:
    567675-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Reducing Gastrointestinal Bleeding with Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism (RADIANT) Pilot Randomized Trial
在急性静脉血栓栓塞中使用质子泵抑制剂治疗减少胃肠道出血 (RADIANT) 试点随机试验
  • 批准号:
    470380
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Operating Grants
Mechanistic analysis of catalysis and regulation of the fungal proton pump Pma1
真菌质子泵Pma1催化与调控的机理分析
  • 批准号:
    BB/V007653/1
  • 财政年份:
    2021
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Research Grant
Big data to inform the impact of antibiotics and proton pump inhibitors on immunotherapies used to treat lung cancer
大数据告知抗生素和质子泵抑制剂对肺癌免疫疗法的影响
  • 批准号:
    nhmrc : 2005294
  • 财政年份:
    2021
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Postgraduate Scholarships
Molecular mechanism underlying organelle trafficking regulated by stractually diverse proton pump vacolar ATPase
结构多样的质子泵空泡 ATP 酶调节细胞器运输的分子机制
  • 批准号:
    21H02627
  • 财政年份:
    2021
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of the activation mechanism of plasma membrane proton pump in stomatal opening
阐明气孔开放质膜质子泵的激活机制
  • 批准号:
    20K06703
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis on the pathogenesis of proton pump inhibitor-associated fundic gland polyps and dysplasia
质子泵抑制剂相关性胃底腺息肉及不典型增生的发病机制分析
  • 批准号:
    20K16174
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Does Cytochrome c Oxidase control proton-pump mechanism by small structural changes?
细胞色素 c 氧化酶是否通过微小的结构变化来控制质子泵机制?
  • 批准号:
    20K03794
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Co-opting of a host proton pump for replication of plant RNA viruses
选择宿主质子泵来复制植物RNA病毒
  • 批准号:
    19K15841
  • 财政年份:
    2019
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Pragmatic Cluster, Randomized, Crossover, Registry-Embedded Clinical Trial of Proton Pump Inhibitors vs. Histamine-2 Receptor Blockers for Stress Ulcer Prophylaxis Therapy in the Intensive Care Unit (PEPTIC Study)
质子泵抑制剂与组胺 2 受体阻滞剂在重症监护病房进行应激性溃疡预防治疗的实用集群、随机、交叉、注册临床试验(PEPTIC 研究)
  • 批准号:
    380177
  • 财政年份:
    2018
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了